HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 141 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $39,000 | -30.4% | 4,454 | 0.0% | 0.00% | – |
| Q2 2022 | $56,000 | -33.3% | 4,454 | 0.0% | 0.00% | – |
| Q1 2022 | $84,000 | -46.2% | 4,454 | 0.0% | 0.00% | – |
| Q4 2021 | $156,000 | -4.3% | 4,454 | 0.0% | 0.00% | – |
| Q3 2021 | $163,000 | -7.4% | 4,454 | -19.2% | 0.00% | – |
| Q4 2020 | $176,000 | -24.1% | 5,513 | -23.1% | 0.00% | – |
| Q3 2020 | $232,000 | +20.2% | 7,171 | +2.7% | 0.00% | – |
| Q2 2020 | $193,000 | +54.4% | 6,984 | 0.0% | 0.00% | – |
| Q1 2020 | $125,000 | +145.1% | 6,984 | +249.2% | 0.00% | – |
| Q4 2019 | $51,000 | +41.7% | 2,000 | 0.0% | 0.00% | – |
| Q3 2019 | $36,000 | -72.7% | 2,000 | -66.7% | 0.00% | – |
| Q2 2019 | $132,000 | +116.4% | 6,000 | +200.0% | 0.00% | – |
| Q1 2019 | $61,000 | +32.6% | 2,000 | 0.0% | 0.00% | – |
| Q4 2018 | $46,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 2,339,885 | $93,421,000 | 21.31% |
| UG Investment Advisers Ltd. | 33,155 | $1,302,000 | 2.52% |
| Pinz Capital Management, LP | 159,400 | $6,260,000 | 1.88% |
| Capital International Sarl | 547,743 | $21,510,000 | 1.86% |
| Capital International, Inc./CA/ | 4,391,684 | $172,461,000 | 1.54% |
| AIA Group Ltd | 437,118 | $17,380,000 | 1.20% |
| York Capital Management Global Advisors, LLC | 182,297 | $7,159,000 | 0.80% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 68,000 | $2,671,000 | 0.70% |
| E Fund Management (Hong Kong) Co., Ltd. | 18,579 | $730,000 | 0.46% |
| M&G INVESTMENT MANAGEMENT LTD | 4,512,562 | $175,990,000 | 0.44% |